Why is Centrus Energy stock sliding today?

Centrus Energy shares dropped 3.9% in after-hours trading after the company announced an underwritten public offering of Class A common stock, pre-funded warrants, and common warrants, a move that points to near-term share dilution and typically prompts existing investors to reprice their positions. The Bethesda, Maryland-based nuclear fuel supplier said it intends to use the net proceeds for general working capital and corporate purposes, which may include technology development, debt repayment, capital expenditures, and potential acquisitions.

The company also disclosed a multi-year contract to supply high-assay, low-enriched uranium (HALEU) to Radiant for its Kaleidos microreactors, with deliveries set to begin before the end of the decade and prepayments from Radiant included to support Centrus's domestic enrichment capacity program. While the Radiant deal reinforces Centrus's expanding commercial HALEU pipeline, market attention stayed focused on the dilutive implications of the equity offering, limiting any upside from the contract news.

The broader U.S. equity market provided little directional influence, with the S&P 500 up just 0.1%, the Dow Jones edging up 0.1%, and the Nasdaq essentially flat on the day. Heading into this announcement, analyst sentiment on LEU was already mixed: Jefferies initiated coverage with a Hold rating in early September, and Stifel trimmed its price target in late August, reflecting concerns about near-term execution risk and valuation even as the long-term nuclear fuel thesis remained intact.

Taken together, an unexpected equity offering—which introduces uncertainty around the offering's final size and terms—combined with the pre-existing cautious analyst backdrop was enough to push LEU meaningfully lower in after-hours trading, even as the Radiant HALEU contract underscored the company's expanding commercial footprint in advanced nuclear fuel.

This article was generated with the support of AI and reviewed by an editor. For more information see our Terms & Conditions.